Home › Funds › HBK INVESTMENTS L P › ANIP
HBK INVESTMENTS L P position in ANIP
ANI PHARMACEUTICALS INC · Health Care
HBK INVESTMENTS L P reported holding 20,150,000 shares of ANIP (ANI PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$23.6M, representing 0.33% of its reported portfolio and ranking #29 among its reported holdings. HBK INVESTMENTS L P has disclosed ANIP holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How HBK INVESTMENTS L P's ANIP position evolved
HBK INVESTMENTS L P first disclosed a stake in ANIP in Q3 2025 at 25,150,000 shares (US$35.3M). Across 5 filings, HBK INVESTMENTS L P increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 20,150,000 shares valued at US$23.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 25.15M | $35.34M | New |
| Q4 2025 | 22.65M | $28.59M | Reduce |
| Q1 2026 | 20.15M | $24.95M | Reduce |
| Q2 2026 | 20.15M | $26.12M | Hold |
| Q3 2026 | 20.15M | $23.61M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANIP and 13F data
ANIP (ANI PHARMACEUTICALS INC) is a Health Care company. 38 other funds we track also report a position in ANIP — the largest reported positions include Soleus Capital Management, L.P. (US$71.8M), TANG CAPITAL MANAGEMENT LLC (US$58.6M), Deep Track Capital, LP (US$36.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANIP
- Soleus Capital Management, L.P. 867.76K sh · $71.83M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 707.50K sh · $58.57M · Q2 2026
- Deep Track Capital, LP 500.00K sh · $36.33M · Q3 2026
- Empyrean Capital Partners, LP 23.00M sh · $29.75M · Q2 2026
- Ikarian Capital, LLC 272.08K sh · $22.52M · Q2 2026
- Ranger Investment Management, L.P. 268.63K sh · $19.52M · Q3 2026
- Boussard & Gavaudan Investment Management LLP 13.35K sh · $16.46M · Q1 2026
More on HBK INVESTMENTS L P
FAQ
How long has HBK INVESTMENTS L P held ANIP?
HBK INVESTMENTS L P has disclosed ANIP holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is HBK INVESTMENTS L P's current position in ANIP?
As of Q3 2026, HBK INVESTMENTS L P holds 20.15M shares of ANIP (ANI PHARMACEUTICALS INC), valued at $23.61M, representing 0.33% of its reported portfolio and ranking #29.
Has HBK INVESTMENTS L P been buying or selling ANIP?
In the latest 13F filing (Q3 2026), HBK INVESTMENTS L P held unchanged its position in ANIP.
Which other funds hold ANIP?
Other major institutional holders of ANIP include Soleus Capital Management, L.P., TANG CAPITAL MANAGEMENT LLC, Deep Track Capital, LP, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.